Today: 14 April 2026
Joby Aviation (JOBY) stock slides premarket after $1.2 billion equity-and-convertible deal
29 January 2026
2 mins read

Joby Aviation (JOBY) stock slides premarket after $1.2 billion equity-and-convertible deal

NEW YORK, Jan 29, 2026, 07:16 EST — Premarket

Shares of Joby Aviation dropped almost 14% in premarket trading Thursday, following a sharp selloff late Wednesday after the electric air-taxi maker announced an upsized stock offering alongside a convertible bond deal. The stock last traded near $11.50, down from Wednesday’s close at $13.37.

This move counts because Joby continues to spend heavily before launching commercial service, and the size of the raise is enough to shift near-term supply and demand dynamics for the stock. Selling equity at a discount often pressures shares by boosting the number investors must digest.

Traders also keep an eye on a mechanical element in these deals. Convertible notes start as debt but can convert to stock down the line, and buyers frequently hedge by shorting shares, which can weigh on pricing and settlement.

Joby priced $600 million of common stock at $11.35 a share, alongside $600 million of 0.75% convertible senior notes due 2032. That boosts total gross proceeds to roughly $1.2 billion, up from the $1.0 billion it announced just a day earlier. Morgan Stanley is also handling a “delta offering” of about 5.29 million borrowed shares at the same $11.35 price, designed to help investors hedge. Joby clarified it won’t receive any proceeds from the borrowed-share sale. Joby Aviation, Inc.

The notes will carry a 0.75% interest rate and mature on Feb. 15, 2032, a company statement reported by Investing.com confirms. Investors can convert these notes at an initial price near $14.19 per share—above Wednesday’s closing price. Joby noted this conversion price implies roughly a 25% premium over the $11.35 delta-offering price.

Joby also executed “capped call” transactions—an options strategy designed to limit dilution from conversions—set with an initial cap price of $22.70 per share, according to a Seeking Alpha release. The company plans to allocate roughly $55 million of the note proceeds toward this capped call, cautioning that related hedging activity could cause volatility in the stock price around the deal. Seeking Alpha

Shares had already slid in extended trading Wednesday after Joby revealed its capital raise plan. According to a Reuters report shared on TradingView, the stock dropped roughly 12.3% after hours, hitting $11.73 following the news.

Joby previously stated it plans to use the proceeds to cover costs for aircraft certification, manufacturing, and gearing up for commercial operations. The remainder will go toward general corporate purposes. The company clarified that the stock and note offerings are independent of each other, though the delta offering and the note sale are linked and contingent on one another.

This is a well-worn pattern for investors in the electric vertical takeoff and landing (eVTOL) sector — emerging developers hitting the markets to bankroll lengthy engineering, certification, and production phases. The real issue isn’t just how much Joby raises now, but how far that money stretches before they need to raise again.

The downside is clear: issuing more shares now, combined with hedging activity, could keep the stock stuck or drive it down—even if the company’s fundamentals stay steady. Joby cautioned in its prospectus supplement that significant share sales and short selling linked to convertible-note hedging might weigh on its common stock price.

Traders will be eyeing whether JOBY holds around the $11.35 deal price when regular trading starts, and how much of the underwriters’ extra-allotment options get snapped up. Joby confirmed the offerings are set to settle on Feb. 2, pending usual closing conditions.

Stock Market Today

  • Bristol Myers Squibb Seen as Value Pharma Play with Stable Dividends in 2026
    April 13, 2026, 10:15 PM EDT. Bristol Myers Squibb (BMS) stands out as a value investment in the pharmaceutical sector heading into 2026. The company trades at a forward price-to-earnings ratio of 9.5, lower than many peers, signaling undervaluation. BMS offers a 4.2% dividend yield and has a long history of dividend growth, raising payouts for 17 straight years and maintaining dividends for 94 years. Revenue held steady near $48 billion in 2024-25, with forecasts projecting a slight decline to $46-47.5 billion this year. Challenges include revenue drops in legacy products and upcoming patent expirations. Additionally, high debt levels and a recent major acquisition weigh on investor sentiment. Nonetheless, BMS's stable cash flow and dividend profile make it attractive amid broader pharma volatility.

Latest article

Marvell Stock Hits Record High After Nvidia’s $2 Billion Move and Amazon AI Chip Push

Marvell Stock Hits Record High After Nvidia’s $2 Billion Move and Amazon AI Chip Push

13 April 2026
Marvell Technology shares rose 2.1% to $131.22 Monday, hitting a record after Nvidia’s $2 billion investment and renewed optimism over Amazon’s AI chip business. The stock earlier touched $135.18. Barclays upgraded Marvell and raised its price target to $150, citing surging demand for optical products in AI data centers. Nvidia and Marvell plan to link custom chips for Nvidia’s NVLink Fusion platform.
Intel Stock Rally Extends as $100 Billion April Run Draws Fresh Wall Street Bets

Intel Stock Rally Extends as $100 Billion April Run Draws Fresh Wall Street Bets

13 April 2026
Intel shares climbed $2.09 to $64.47 by late morning Monday, extending a rally that has added over $100 billion in value across eight sessions. The surge follows a raised price target, new deals with Google and Elon Musk’s Terafab, and Intel’s $14.2 billion buyback of Apollo’s Fab 34 stake. The stock is up 69% in 2026 after an 84% gain last year. Intel reports first-quarter results April 23.
Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

13 April 2026
Nebius Group shares climbed 7.4% to $155.74 by midday Monday after Bank of America raised its price target to $175, despite Freedom Capital Markets downgrading the stock to Hold. The Amsterdam-based AI infrastructure firm recently secured a five-year deal with Meta worth up to $27 billion and holds over $40 billion in supply contracts with Microsoft and Meta. Nebius also closed $4.34 billion in convertible debt and sold $2 billion in warrants to Nvidia.
Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old

Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old

13 April 2026
Salesforce faced renewed attention after reports of stake reductions by Choreo LLC and Sumitomo Mitsui Trust Group, based on SEC filings from January that reflected year-end positions. Choreo held 27,733 shares and Sumitomo Mitsui 2,478,864 shares as of December 31. The reported cuts amounted to about 35% and 8.6%, respectively. Salesforce shares rose 3.4% Monday, while broader software stocks remain down for the year.
Nordea Bank stock slips after Q4 profit rise; dividend lifted and buybacks stay in focus
Previous Story

Nordea Bank stock slips after Q4 profit rise; dividend lifted and buybacks stay in focus

Microsoft stock slides 10% after earnings beat as Azure outlook, AI bill unsettle Wall Street
Next Story

Microsoft stock slides 10% after earnings beat as Azure outlook, AI bill unsettle Wall Street

Go toTop